Masimo (NASDAQ: MASI) today announced that it has successfully completed the acquisition of the LiDCO Group Plc, a leading provider of advanced hemodynamic monitoring solutions (LiDCO). The Company completed the acquisition of 100% of LiDCO on February 2, 2021. Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions.
Read the full article: Masimo Expands Suite of Advanced Measurements through Acquisition of UK-Based LiDCO Group Plc //
Source: https://www.businesswire.com/news/home/20210202005097/en/Masimo-Expands-Suite-of-Advanced-Measurements-Through-Acquisition-of-UK-Based-LiDCO-Group-Plc